Nanovibronix, inc. (NAOV)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities:
Net loss

-5,794

-5,798

-6,309

-6,044

-4,154

-4,598

-4,853

-4,877

-4,965

-4,444

-3,451

-3,213

-2,831

-2,492

-2,925

-2,749

-2,884

-2,903

-2,630

-2,774

-2,647

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

-

-

-

-

-

3

3

6

5

7

8

6

7

8

8

9

9

10

11

9

9

0

0

0

Stock-based compensation

1,755

1,779

2,167

2,115

889

783

432

558

800

907

923

794

508

351

260

275

220

163

95

31

24

0

0

0

Noncash interest expense

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant modification expense

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discount amortization of promissory notes

-

-

-

-

-

332

877

1,192

1,197

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Benefit component of Promissory Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

Revaluation of warrants to purchase Common stock

-

-

-

-

-

256

680

514

549

485

105

417

383

501

1,145

988

962

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Trade receivable

-

-

-

-

-

-

-

-

-

-

-

-

1

5

-7

-7

-16

0

0

0

-

-

-

-

Valuation of warrants to purchase Common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Trade receivable

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Other accounts receivable and prepaid expenses

173

0

0

0

-

-

-

-

-

-

-

-

-44

-6

25

397

67

-8

35

-394

-33

0

0

0

Inventory

-23

0

0

0

-

-

-

-

-

-

-

-

-4

-11

6

47

36

39

-10

-44

-31

0

0

0

Increase in trade payables

-

-

-

-

-

-

-

-

-

-

-

-

24

0

0

0

-

-

-

-

-

-

-

0

Trade payables

-64

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Other accounts payable

-

0

0

0

-

-

-

-

-

-

-

-

244

103

63

299

-105

-182

-6

-169

183

0

0

0

Changes in operating assets and liabilities

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued severance pay, net

-

0

0

47

-

18

3

2

4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase in accrued severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

90

0

0

12

-1

0

0

0

-

-

-

-

Net cash used in investment activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-8

-1

0

0

0

-

-

-

-

Decrease in accrued severance pay, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accrued interest on Promissory Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in operating activities

-3,874

-3,723

-3,408

-3,620

-3,550

-3,449

-3,134

-2,644

-2,182

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Cash flows from investing activities:
Accrued interest on Promissory Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

65

0

0

0

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,484

-1,543

-1,480

0

0

0

-

-

-

-

Purchases of property plant and equipment

-

-

-

-

8

0

0

2

-

2

2

1

8

8

8

8

1

0

0

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-8

0

0

-2

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Proceeds from issuance of Convertible Promissory Note and warrants

-

-

-

0

-

0

350

1,030

1,380

0

0

0

-

-

-

0

3,005

0

0

0

-

-

0

0

Proceeds from exercise of options

-

-

-

-

-

-

-

-

-

-

-

-

33

33

33

33

0

0

0

0

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

33

3,005

0

0

0

-

-

-

-

Proceeds from issuance of Promissory Notes and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

4,316

4,254

3,267

319

94

5,100

5,437

6,086

6,436

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Net increase in cash and cash equivalents

442

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

1,645

2,300

3,440

4,254

-450

-584

-1,227

-1,508

-1,462

-1,459

-1,518

1,524

1,956

2,152

2,759

-4

0

0

0

Discount on convertible notes

414

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

86

0

0

0

Conversion of Promissory Notes into Preferred B-1, B-2 stock and Preferred C stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,066

5,066

5,066

3,457

0

0

0

0